오스트레일리아 -
영어 -
Department of Health (Therapeutic Goods Administration)
vabysmo faricimab 120 mg/ml solution for injection vial
roche products pty ltd - faricimab, quantity: 120 mg/ml - injection, solution - excipient ingredients: histidine; acetic acid; methionine; sodium chloride; sucrose; polysorbate 20; water for injections - vabysmo is indicated for the treatment of:,- neovascular (wet) age-related macular degeneration (namd),- diabetic macular oedema (dmo).
